Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: investor sentiment...

I agree regarding possible warrant conversion.. Would that not explain why our OS has increased.. hopefully as S&L's warrant holdings continue to be reduced?? If that were to be the case, I would/will definitaley trade a probable short term pps decrease for reduction of warrants, and better long term health for all.. especially if PTSC were to be smart enough to repurchase shares at the same time at these reduced prices.. even if it meant having to borrow against future MMP revenues to cover all the costs.

Corrections in 'logic' welcomed

Share
New Message
Please login to post a reply